Skip to content
10-Q

Quarterly Report

Durata Therapeutics, Inc.

0001193125-14-188738

← back to feed
Filed
May 8, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Apr 30, 2014 26.64M sh
Capex Q1 2014 · Mar 31, 2014 $1.16M
Capex restated Q1 2014 · Mar 31, 2013 $402K
Long Term Debt Q1 2014 · Mar 31, 2014 $24.69M
Long Term Debt Q1 2014 · Dec 31, 2013 $25M
Short Term Debt Q1 2014 · Mar 31, 2014 $313K
Cash And Equivalents Q1 2014 · Mar 31, 2014 $20.67M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $36.85M
Cash And Equivalents restated Q1 2014 · Mar 31, 2013 $32.64M
Cash And Equivalents restated Q1 2014 · Dec 31, 2012 $32.26M
Stockholders Equity Q1 2014 · Mar 31, 2014 $19.47M
Stockholders Equity Q1 2014 · Dec 31, 2013 $38.58M
Current Liabilities Q1 2014 · Mar 31, 2014 $13M
Current Liabilities Q1 2014 · Dec 31, 2013 $14M
Total Liabilities Q1 2014 · Mar 31, 2014 $62.94M
Total Liabilities Q1 2014 · Dec 31, 2013 $61.57M
Current Assets Q1 2014 · Mar 31, 2014 $45.5M
Current Assets Q1 2014 · Dec 31, 2013 $63.1M
Total Assets Q1 2014 · Mar 31, 2014 $82.41M
Total Assets Q1 2014 · Dec 31, 2013 $100.14M
Rd Expense Q1 2014 · Mar 31, 2014 $9.01M
Rd Expense Q1 2014 · Mar 31, 2014 $133.17M
Rd Expense restated Q1 2014 · Mar 31, 2013 $11.09M
Net Income Q1 2014 · Mar 31, 2014 −$19.96M
Net Income Q1 2014 · Mar 31, 2014 −$189.4M
Net Income restated Q1 2014 · Mar 31, 2013 −$15.77M
Operating Income Q1 2014 · Mar 31, 2014 −$18.94M
Operating Income Q1 2014 · Mar 31, 2014 −$189.09M
Operating Income restated Q1 2014 · Mar 31, 2013 −$15.43M
Stock Issued Q1 2014 · Apr 17, 2013 8.22M sh
Stock Issued Q1 2014 · Jul 31, 2012 8.63M sh